


SparingVision Raises €75 Million Series B to Continue Building World-Leading Portfolio of Genomic Medicines for Ocular Diseases

Agomab Therapeutics Selected as One of Fierce Biotech’s “Fierce 15” Companies of 2022

Thabor Therapeutics appoints Jérémie Mariau as CEO
